Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Telomeres are DNA-protein structures that form a protective cap on chromosome ends. As such, they prevent the natural ends of linear chromosomes from being subjected to DNA repair activities that would result in telomere fusion, degradation or recombination. Both the DNA and protein components of the telomere are required for this essential function, as insufficient telomeric DNA length, loss of the terminal telomeric DNA structure, or deficiency of key telomere-associated factors may elicit a DNA damage response and result in cellular senescence or apoptosis. In the setting of failed checkpoint mechanisms, such DNA-protein defects can also lead to genomic instability through telomere fusions or recombination. Thus, as shown in both model systems and in humans, defects in telomere biology are implicated in cellular and organismal aging as well as in tumorigenesis. Bone marrow failure and malignancy are two life threatening disease manifestations in the inherited telomere biology disorder, dyskeratosis congenita. Here, we provide an overview of basic telomere structure and maintenance. We outline the telomere biology defects observed in dyskeratosis congenita, focusing on recent discoveries in this field. Lastly, we review the evidence of how telomere biology may impact sporadic aplastic anemia and the risk for various cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 2×
“Mammalian telomeres are comprised of tandem repeats of a T2AG3/C3TA2 nucleotide sequence coated with a telomere-dedicated complex known as shelterin.(1,2) Along with shelterin are a number of other factors that also contribute significantly to other aspects of chromosome biology.”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“On reaching a critically short length, a DNA damage checkpoint response is triggered and cellular senescence induced.(28,29) In contrast, forced TERT expression can restore telomerase activity, extend telomeres, and convey cellular immortality in a variety of human somatic cells.”
BackgroundMammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 1×
“On reaching a critically short length, a DNA damage checkpoint response is triggered and cellular senescence induced.(28,29) In contrast, forced TERT expression can restore telomerase activity, extend telomeres, and convey cellular immortality in a variety of human somatic cells.”
BackgroundEvidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9857 · Cited by 1,132 · cited 2×
“Although CD341 hematopoietic stem cells express low levels of telomerase that can be upregulated transiently, telomere length in the hematopoietic stem cell compartment shortens progressively with age and is associated with a decline in proliferative potential in vitro.(8) Therefore, shorter telomere length resulting…”
BackgroundVaziri, H., & Benchimol, S. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70109-5 · Cited by 1,003 · cited 1×
“In contrast, forced TERT expression can restore telomerase activity, extend telomeres, and convey cellular immortality in a variety of human somatic cells.(30,31) Correspondingly, TERT expression and, consequently, telomerase activity, are upregulated in approximately 90% of primary tumors, thereby removing the telome…”
BackgroundMammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication
Sfeir, A., Kosiyatrakul, S. T., Hockemeyer, D., MacRae, S. L., Karlseder, J., Schildkraut, C. L., & de Lange, T. (2009) · Cell · doi:10.1016/j.cell.2009.06.021 · Cited by 990
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723
A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis
Venteicher, A. S., Abreu, E. B., Meng, Z., McCann, K. E., Terns, R. M., Veenstra, T. D., Terns, M. P., & Artandi, S. E. (2009) · Science · doi:10.1126/science.1165357 · Cited by 522
Telomere length and risk of incident cancer and cancer mortality
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010) · JAMA · doi:10.1001/jama.2010.897 · Cited by 484 · cited 1×
“84) for the shortest telomere length group, compared with the longest telomere group, further suggesting that shortened telomeres may be a marker for cancer susceptibility.(110) As a result, telomere shortening that occurs naturally with age also has been proposed as a mechanism for the increased cancer risk observed…”
BackgroundCancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood · doi:10.1182/blood-2008-12-192880 · Cited by 478
The association of telomere length and cancer: a meta-analysis
Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0005 · Cited by 458 · cited 1×
“Although results from individual studies are somewhat conflicting, when taken together, 2 metaanalyses including data from 27 publications have demonstrated an overall increased risk for cancer with shortened telomere length.(108,109) In addition, the risk for developing de novo cancers has been estimated in healthy i…”
ResultArmanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452
Flow cytometry and FISH to measure the average length of telomeres (flow FISH)
Baerlocher, G. M., Vulto, I., de Jong, G., & Lansdorp, P. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.263 · Cited by 449
Savage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · cited 4×
“In contrast to the aforementioned genes, the remaining known DC-associated genes—TINF2, CTC1, and RTEL1—do not appear to impact telomere length through direct effects on telomerase.(46,61,62) TINF2 encodes the shelterin component TIN2.”
BackgroundResultInfluentialShortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis
Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K. A., Dunning, A. M., Svenson, U., Roos, G., Hosgood, H. D., Shen, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020466 · Cited by 376 · cited 1×
“Although results from individual studies are somewhat conflicting, when taken together, 2 metaanalyses including data from 27 publications have demonstrated an overall increased risk for cancer with shortened telomere length.(108,109) In addition, the risk for developing de novo cancers has been estimated in healthy i…”
ResultAlter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356 · cited 2×
“Although DC is a genetically heterogeneous disorder with mutations in 9 genes reported to date, a nearly universally molecular feature is excessively short telomeres.(53) Each of the DC-associated genes contributes to some aspect of telomere maintenance and function.”
BackgroundResultMiyake, Y., Nakamura, M., Nabetani, A., Shimamura, S., Tamura, M., Yonehara, S., Saito, M., & Ishikawa, F. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.009 · Cited by 350
Aubert, G., Hills, M., & Lansdorp, P. M. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.04.003 · Cited by 342 · cited 1×
“Southern blotting is considered by many to be the gold standard.(40) In this technique, telomeric terminal restriction fragments (TRFs) are separated from heavily restriction-digested genomic DNA by gel electrophoresis and detected by hybridization with a telomeric probe, resulting in a report of mean TRF lengths.”
BackgroundVulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A., & Dokal, I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800042105 · Cited by 334 · cited 1×
“NOP10 and NHP2 mutations, together reported in just a few patients to date, are associated with decreased TERC levels, suggesting they lead to telomere shortening through decreased levels of telomerase.(57,58) In contrast to the aforementioned genes, the remaining known DC-associated genes—TINF2, CTC1, and RTEL1—do no…”
BackgroundWalne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I. (2008) · Blood · doi:10.1182/blood-2008-05-153445 · Cited by 317 · cited 2×
“The DCassociated mutations in this gene are autosomal dominant and comprise a substantial proportion of DC cases, between 10% and 30% in 2 large cohorts.(46,63) In contrast to individuals carrying heterozygous mutations in TERT or TERC, TINF2 mutations present most frequently in early childhood and are often de novo,…”
BackgroundWalne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm111 · Cited by 316 · cited 1×
“NOP10 and NHP2 mutations, together reported in just a few patients to date, are associated with decreased TERC levels, suggesting they lead to telomere shortening through decreased levels of telomerase.(57,58) In contrast to the aforementioned genes, the remaining known DC-associated genes—TINF2, CTC1, and RTEL1—do no…”
BackgroundMutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome
Yamaguchi, H., Baerlocher, G. M., Lansdorp, P. M., Chanock, S. J., Nunez, O., Sloand, E., & Young, N. S. (2003) · Blood · doi:10.1182/blood-2003-01-0335 · Cited by 301 · cited 2×
“First, an increased incidence of both known and novel deleterious TERT and TERC variants (confirmed by telomerase functional analysis) has been noted in 2 cohorts of largely adult patients with apparently acquired aplastic anemia, none of whom had been diagnosed with an inherited bone marrow failure disorder.(6,80) Se…”
BackgroundFogarty, P. F., Yamaguchi, H., Wiestner, A., Baerlocher, G. M., Sloand, E., Zeng, W. S., Read, E. J., Lansdorp, P. M., & Young, N. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14797-6 · Cited by 277
Savage, S. A., & Alter, B. P. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.003 · Cited by 262
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development · doi:10.1101/gad.2006411 · Cited by 262
Scheinberg, P., Cooper, J. N., Sloand, E. M., Wu, C. O., Calado, R. T., & Young, N. S. (2010) · JAMA · doi:10.1001/jama.2010.1376 · Cited by 205
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Calado, R. T., Regal, J. A., Hills, M., Yewdell, W. T., Dalmazzo, L. F., Zago, M. A., Lansdorp, P. M., Hogge, D., Chanock, S. J., Estey, E. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807057106 · Cited by 184 · cited 3×
“One telomerase variant, TERT A1062 T, although found in the general population as a rare polymorphism, is also significantly enriched in adults with a variety of hematopoietic malignancies including AML, CLL, and diffuse, large B-cell lymphoma.(102,103) For many of the variants described in both the aplastic anemia an…”
BackgroundLin, T. T., Letsolo, B. T., Jones, R. E., Rowson, J., Pratt, G., Hewamana, S., Fegan, C., Pepper, C., & Baird, D. M. (2010) · Blood · doi:10.1182/blood-2010-02-272104 · Cited by 178
Du, H.-Y., Pumbo, E., Ivanovich, J., An, P., Maziarz, R. T., Reiss, U. M., Chirnomas, D., Shimamura, A., Vlachos, A., Lipton, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-07-166421 · Cited by 158
CTC1 Mutations in a patient with dyskeratosis congenita
Keller, R. B., Gagne, K. E., Usmani, G. N., Asdourian, G. K., Williams, D. A., Hofmann, I., & Agarwal, S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24193 · Cited by 138 · cited 8×
“The DCassociated mutations in this gene are autosomal dominant and comprise a substantial proportion of DC cases, between 10% and 30% in 2 large cohorts.46,63 In contrast to individuals carrying heterozygous mutations in TERT or TERC, TINF2 mutations present most frequently in early childhood and are often de novo, as…”
BackgroundResultInfluentialBeier, F., Foronda, M., Martinez, P., & Blasco, M. A. (2012) · Blood · doi:10.1182/blood-2012-03-418038 · Cited by 79
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia
Savage, S. A., Calado, R. T., Xin, Z.-T., Ly, H., Young, N. S., & Chanock, S. J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.02.008 · Cited by 47 · cited 1×
“However, directed sequencing of TRF1 and genes encoding the other remaining shelterin components, TRF2, repressor/activator protein 1, TPP1, and POT1, in a cohort of 16 genetically uncharacterized DC or DC-like probands did not reveal any definitive disease-associated variants.(73,74) Similarly, although the identific…”
Background
Cited by
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Zink, F., Stacey, S. N., Norddahl, G. L., Frigge, M. L., Magnusson, O. T., Jonsdottir, I., Thorgeirsson, T. E., Sigurdsson, A., Gudjonsson, S. A., Gudmundsson, J., et al. (2017) · Blood · doi:10.1182/blood-2017-02-769869 · Cited by 777
Telomeropathies: An emerging spectrum disorder
Holohan, B., Wright, W. E., & Shay, J. W. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201401012 · Cited by 175
“However, telomeropathies are characterized by persistent DNA damage signals at the telomeres, telomere fusions, and genomic rearrangements driven by telomere repair-mediated recombination (Gramatges and Bertuch, 2013).”
Metadata
- Authors
- Gramatges, M. M., & Bertuch, A. A.
- Venue
- Translational Research
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 162
- Issue
- 6
- Pages
- 353-363
- ISSN
- 1878-1810 (ISSN-L)
- 1931-5244
- OpenAlex
- W2054461612
- Cited by
- 88
- References
- 38
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.